BRAVECTO PLUS BLUE MEDIUM 2 PIPETTES
Bravecto Plus Spot-On solution for cats 2.8 - 6.25kg
2 Pippettes
Bravecto Plus is the first spot-on solution for cats to protect against fleas and ticks for 12 weeks and treats ear mites and a broad spectrum of worms1. It contains fluralaner and moxidectin.
Active ingredients
Each ml of solution contains 280 mg fluralaner and 14 mg moxidectin
Target Species
Cats
Indications for use
For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when used against ticks or fleas and one or more of the other target parasites is indicated at the same time.
For the treatment of tick and flea infestations in cats providing immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
For the treatment of infestations with ear mites (Otodectes cynotis).
For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma tubaeforme).
When administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by Dirofilaria immitis.
2 Pippettes
Bravecto Plus is the first spot-on solution for cats to protect against fleas and ticks for 12 weeks and treats ear mites and a broad spectrum of worms1. It contains fluralaner and moxidectin.
Active ingredients
Each ml of solution contains 280 mg fluralaner and 14 mg moxidectin
Target Species
Cats
Indications for use
For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when used against ticks or fleas and one or more of the other target parasites is indicated at the same time.
For the treatment of tick and flea infestations in cats providing immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
For the treatment of infestations with ear mites (Otodectes cynotis).
For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma tubaeforme).
When administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by Dirofilaria immitis.